MENU
+Compare
NDRA
Stock ticker: NASDAQ
AS OF
Oct 6, 04:54 PM (EDT)
Price
$6.23
Change
+$0.48 (+8.35%)
Capitalization
4.67M

NDRA ENDRA Life Sciences Inc Forecast, Technical & Fundamental Analysis

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care... Show more

Industry: #Biotechnology
NDRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NDRA with price predictions
Oct 03, 2025

NDRA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for NDRA turned positive on September 03, 2025. Looking at past instances where NDRA's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 10, 2025. You may want to consider a long position or call options on NDRA as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NDRA moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NDRA crossed bullishly above the 50-day moving average on September 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NDRA advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NDRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NDRA broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NDRA entered a downward trend on September 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NDRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.174) is normal, around the industry mean (9.455). P/E Ratio (0.011) is within average values for comparable stocks, (136.052). NDRA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.777). NDRA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.000) is also within normal values, averaging (9.153).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NDRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
NDRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of medical imaging technology solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3600 Green Court
Phone
+1 734 335-0468
Employees
21
Web
https://www.endrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCG4.000.09
+2.30%
Oriental Culture Holding Ltd
VTRS10.190.08
+0.79%
Viatris
CVGW26.170.20
+0.77%
Calavo Growers
BDRX6.700.03
+0.45%
Biodexa Pharmaceuticals plc
ADUS114.86-0.59
-0.51%
Addus HomeCare Corp

NDRA and Stocks

Correlation & Price change

A.I.dvisor tells us that NDRA and GMED have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDRA and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDRA
1D Price
Change %
NDRA100%
-0.52%
GMED - NDRA
29%
Poorly correlated
+4.17%
ICUI - NDRA
24%
Poorly correlated
+0.96%
CNMD - NDRA
23%
Poorly correlated
+3.28%
PSNL - NDRA
22%
Poorly correlated
+8.42%
EXAS - NDRA
22%
Poorly correlated
+0.94%
More